A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia
Public ClinicalTrials.gov record NCT01358734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Open-label, Parallel-group Study of a Lenalidomide (Revlimid®) Regimen or a Sequential Azacitidine (Vidaza®) Plus Lenalidomide (Revlimid®) Regimen Versus an Azacitidine (Vidaza®) Regimen for Therapy of Older Subjects With Newly Diagnosed Acute Myeloid Leukemia
Study identification
- NCT ID
- NCT01358734
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Celgene
- Industry
- Enrollment
- 88 participants
Conditions and interventions
Conditions
Interventions
- Azacitidine Drug
- Best Supportive Care (BSC) Other
- Lenalidomide Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 26, 2012
- Primary completion
- May 18, 2015
- Completion
- May 14, 2018
- Last update posted
- Jun 24, 2019
2012 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| (210) University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| (180) University of California, San Diego | La Jolla | California | 92093-0960 | — |
| (240) Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| (215) Hematology Oncology Medical Group | Orange | California | 92868 | — |
| (130) UC Davis Medical Center | Sacramento | California | 95857 | — |
| (200) Coastal Integrative Cancer Care | San Luis Obispo | California | 93401 | — |
| (125) University of Stanford | Stanford | California | 94305 | — |
| (115) University of Colorado Anschultz Cancer Center | Aurora | Colorado | 80045 | — |
| (145) Mount Sinai Comprehensive Cancer Center | Miami Beach | Florida | 33140 | — |
| (140) Rush University Medical Center | Chicago | Illinois | 60612 | — |
| (185) The University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| (175) University Lousiville | Louisville | Kentucky | 40202 | — |
| (195) Tulane University Hospital Tulane Cancer Center | New Orleans | Louisiana | 70072 | — |
| (235) University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| (100) Washington University School of Medicine | St Louis | Missouri | 63110-1093 | — |
| (150) Billings Clinic | Billings | Montana | 59101 | — |
| (165) Mount Sinai Medical Center New York | New York | New York | 10029-65749 | — |
| (160) The Western Pennsylvania Hospital- Cancer Institute | Pittsburgh | Pennsylvania | 15224-1791 | — |
| (205) Greenville Hospital System | Greenville | South Carolina | 29605 | — |
| (120) Avera Cancer Institute | Sioux Falls | South Dakota | 57105 | — |
| (230) Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| (105) University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center | Dallas | Texas | 75390-9179 | — |
| (155) Cancer Care Centers of South Texas | San Antonio | Texas | 78229 | — |
| (135) University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01358734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2019 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01358734 live on ClinicalTrials.gov.